Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK7653 tablets in Chinese patients with type 2 diabetes mellitus replacing DPP-4 inhibitors
CTR20240037Phase 2Completed
- Sponsor
- Sichuan Haisco Pharmaceutical Co., Ltd.
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cofrogliptin in type 2 diabetes mellitus (T2DM), sponsored by Sichuan Haisco Pharmaceutical Co., Ltd.. Started Jan 2024; status: completed.
02
Drugs
cofrogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20240037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240037.